CareAtHome Medical Group, alongside Vesta Healthcare, has been chosen by the Centers for Medicare & Medicaid Services (CMS) to participate in the innovative GUIDE Model, starting July 2025. This Medicare alternative payment model aims to support individuals with dementia and…
Galderma has announced the U.S. exclusive launch of two new innovations in its Cetaphil product line: the Vitamin C Serum and the Ceramide Serum. According to clinical studies, the Cetaphil Vitamin C Serum has shown impressive results: 95% of participants…
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced the reintroduction of Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant in the United States (U.S.) for the treatment of individuals with wet,…
Element Science, a leader in health technology, has proudly announced that its Jewel® Wearable Patch Cardioverter Defibrillator (Jewel) has been honored with the prestigious Red Dot Design Award. This recognition underscores Jewel’s exceptional design, focused on patient comfort and continuous…
Pint Pharma is pleased to announce that ORLADEYO® (berotralstat) has been approved by the General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru for daily oral use in the prophylaxis of hereditary angioedema (HAE) attacks in adult and pediatric…
Amplar Home Health, a leading provider of in-home care services in Australia, has unveiled its new headquarters in Adelaide. This purpose-built facility represents a significant step forward in Amplar Health’s mission to innovate healthcare delivery across the country. The Hon.…
Chemed Corporation (NYSE: CHE) announced today that it will release its financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, after the close of trading on the New York Stock Exchange. Following the release,…
Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to promoting healthier lifestyles, announced today that it will unveil its 2024 second quarter financial results at around 6:00 a.m. ET on Friday, July 26, 2024. Subsequently, the company will host…
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or “Company”), a clinical-stage biotechnology firm pioneering targeted virotherapies, has confirmed that its Board of Directors has sanctioned a reverse stock split of its outstanding common stock at a ratio of 1-for-10 (the…
MySpaLive, a leader in the aesthetics industry, is thrilled to announce its expansion into five new states: Arizona, Arkansas, Oklahoma, Washington, and Georgia. This strategic move aims to provide Registered Nurses (RNs) and above with accessible medical director coverage starting…
Atara Biotherapeutics, Inc. (Nasdaq: ATRA) has granted 2,200 restricted stock units of its common stock to a newly hired employee. Approved by the Compensation Committee of Atara’s Board of Directors, this grant was made under the Atara Biotherapeutics, Inc. 2018…
Inogen, Inc. (Nasdaq: INGN), a leading medical technology company specializing in innovative respiratory products for homecare, has appointed Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex…